Antimicrobial activity of gatifloxacin against nosocomial Stenotrophomonas maltophilia measured by MIC and time kill studies.

被引:0
|
作者
Cohn, ML [1 ]
Waites, KB [1 ]
机构
[1] Univ Alabama, Dept Pathol, Birmingham, AL 35233 USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
32
引用
收藏
页码:307 / 308
页数:2
相关论文
共 45 条
  • [21] MIC and time-kill studies of antipneumococcal activity of CV 118819X (Sanfetrinem) compared with those of other agents
    Spangler, SK
    Jacobs, MR
    Appelbaum, PC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (01) : 148 - 155
  • [22] Activity of moxifloxacin and cefuroxime against MSSA in time-kill and in vitro PK/PD studies
    Endermann, R.
    Weskott, G.
    Pickbrenner, A.
    Schuhmacher, J.
    Knezevic, I.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S170 - S171
  • [23] In Vitro Activities of Echinocandins against Candida krusei Determined by Three Methods: MIC and Minimal Fungicidal Concentration Measurements and Time-Kill Studies
    Canton, Emilia
    Peman, Javier
    Valentin, Amparo
    Espinel-Ingroff, Ana
    Gobernado, Miguel
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (07) : 3108 - 3111
  • [24] In vitro activities of echinocandins against Candida lusitaniae determined by three methods: MIC and minimal fungicidal concentration measurements and time-kill studies
    Espinel-Igroff, A.
    Canton, E.
    Peman, J.
    [J]. MYCOSES, 2011, 54 : 167 - 168
  • [25] Activity of HMR 3647 compared to those of five agents against Haemophilus influenzae and Moraxella catarrhalis by MIC determination and time-kill assay
    Pankuch, GA
    Hoellman, DB
    Lin, GR
    Bajaksouzian, S
    Jacobs, MR
    Appelbaum, PC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) : 3032 - 3034
  • [26] Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia
    Arianna Pompilio
    Valentina Crocetta
    Marco Scocchi
    Stefano Pomponio
    Valentina Di Vincenzo
    Mario Mardirossian
    Giovanni Gherardi
    Ersilia Fiscarelli
    Giordano Dicuonzo
    Renato Gennaro
    Giovanni Di Bonaventura
    [J]. BMC Microbiology, 12
  • [27] Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia
    Pompilio, Arianna
    Crocetta, Valentina
    Scocchi, Marco
    Pomponio, Stefano
    Di Vincenzo, Valentina
    Mardirossian, Mario
    Gherardi, Giovanni
    Fiscarelli, Ersilia
    Dicuonzo, Giordano
    Gennaro, Renato
    Di Bonaventura, Giovanni
    [J]. BMC MICROBIOLOGY, 2012, 12
  • [28] Activity of Antimicrobial Combinations against KPC-2-Producing Klebsiella pneumoniae in a Rat Model and Time-Kill Assay
    Michelon Toledo, Paula Virginia
    Aranha Junior, Ayrton Alves
    Arend, Lavinia Nery
    Ribeiro, Vanessa
    Zavascki, Alexandre Prehn
    Tuon, Felipe Francisco
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (07) : 4301 - 4304
  • [29] DIFFERENCES IN THE INVITRO INHIBITORY AND BACTERICIDAL ACTIVITY OF CEFTIZOXIME, CEFOXITIN, CEFOTETAN, AND PENICILLIN-G AGAINST BACTEROIDES-FRAGILIS GROUP ISOLATES - COMPARISON OF TIME KILL KINETIC-STUDIES WITH MIC VALUES
    ALDRIDGE, KE
    WEEKS, LS
    STRATTON, CW
    SANDERS, CV
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1990, 13 (04) : 311 - 316
  • [30] Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae
    Kim, BN
    Woo, JH
    Kim, YS
    Ryu, J
    Kim, MN
    Pai, CH
    [J]. CHEMOTHERAPY, 2000, 46 (05) : 303 - 308